Sintalica is a drug discovery company focused on Psilocybin and tryptamine derivatives for psychedelic-assisted therapies for a variety of targeted health conditions.
We are uniquely specialized in proprietary synthesizing psychedelics, formulating drugs, and developing new treatments.
Our team of experienced professionals stays current about the latest drug developments.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Find investors for your startup like Sintalica Bioscience
Gritt sends AI-personalised outreach to each investor — from your Gmail